Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
23,165,208
-
Total 13F shares
-
382,167
-
Share change
-
+382,167
-
Total reported value
-
$2,847,155
-
Price per share
-
$7.45
-
Number of holders
-
10
-
Value change
-
+$2,847,152
-
Number of buys
-
10
Institutional Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) as of Q3 2024
As of 30 Sep 2024,
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
382,167 shares.
The largest 10 holders included
AWM Investment Company, Inc., Long Corridor Asset Management Ltd, Royal Bank of Canada, GEODE CAPITAL MANAGEMENT, LLC, NORTHWESTERN UNIVERSITY, KG&L Capital Management,LLC, CITIGROUP INC, WELLS FARGO & COMPANY/MN, Tower Research Capital LLC (TRC), and BANK OF AMERICA CORP /DE/.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.